Divestments

Clinical Innovations

Clinical Innovations is the leading, global pure-play provider of single-use clinician-preferred medical devices for hospitals’ Labor & Delivery (L&D) and Neonatal Intensive Care Unit (NICU) departments.

Founded in 1993, Clinical Innovations is the largest independent medical device company exclusively focused on L&D.

  • Sektor
    Healthcare
  • Land
    United States
  • Fond
    EQT Mid Market US,EQT Mid Market Asia III
  • Entry
    2017
  • Exit
    2020-02-01

Already a market leader in several categories with products such as the Kiwi® Vacuum-Assisted Delivery System and Koala® Intrauterine Pressure Catheter, Clinical Innovations is developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and babies around the world. The Company has a well-balanced L&D and NICU portfolio of best-in-class, market-leading, established products as well as high-growth new products.

Clinical Innovations has built the industry’s largest specialized L&D-focused sales force and has developed strong relationships with specialty medical device distributors around the world.

In February, 2020, EQT sold Clinical Innovations to LABORIE Medical Technologies.

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
En syftesdriven global investeringsorganisation
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180